Patients' experiences of intervention trials on the treatment of myocardial infarction: Is it time to adjust the informed consent procedure to the patient's capacity?

Heart

Volumn 86, Issue 6, 2001, Pages 632-637

  Agard A ^a   Hermeren G ^b   Herlitz, J ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Acute myocardial infarction; Clinical trial; Informed consent; Patient attitudes

Indexed keywords

ABCIXIMAB; ALTEPLASE; DALTEPARIN; FIBRINOLYTIC AGENT; HEPARIN; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPETENCE; COMPREHENSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DECISION MAKING; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INFORMED CONSENT; INTERVIEW; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035189947     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.6.632     Document Type: Article

References (28)

1. Trial of tissue plasminogen activator for mortality in acute myocardial infarction. Anglo-Scandinavian study of early hrombolysis (ASSET)
2. Very early thrombolytic therapy in suspected acute myocardial infarction
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
4. A comparison of reteplase with alteplase for acute myocardial infarction
5. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial. Assessment of the safety and efficacy of a new thrombolytic investigators
6. The consent process in the thrombolysis in myocardial infarction (TIMI, phase I) trial
7. Myocardial infarction: Case studies of ethics in the consent situation
8. Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?
9. Informed consent in emergency research. Consensus statement from the coalition conference of acute resuscitation and critical care researchers
10. Initial experience using the Food and Drug Administration guidelines for emergency research without consent
11. Informed consent in emergency research. Prehospital thrombolytic therapy for acute myocardial infarction
12. The masquerades of myocardial infarction
13. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study
14. Rigour and qualitative research
15. Qualitative research interview
16. Qualitative interviews in medical research
17. The Nuremberg code and the Nuremberg trial. A reappraisal
18. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects
19. New guidelines on research ethics from CIOMS (Council of International Organizations of Medical Sciences). A good example of balancing autonomy, benefits and human rights
20. Is informed consent an "upside selective" process in acute coronary syndromes?
21. Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction
22. Informed consent for biomedical research in acute care medicine
23. Research in emergency situations. The role of deferred consent
24. Task force 3. Special aspects of research conduct in emergency setting: Waiver of informed consent
25. Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department